Therapeutic implications of autophagy-mediated cell survival in gastrointestinal stromal tumor after treatment with imatinib mesylate

Autophagy

Volumn 6, Issue 8, 2010, Pages 1190-1191

  Rubin, Brian P ^a   Debnath, Jayanta ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autophagy; Autophagy inhibitors; GIST; Imatinib mesylate; KIT; PDGFRA; Small molecule tyrosine kinase inhibitors

Indexed keywords

IMATINIB;

AUTOPHAGY; CANCER THERAPY; CELL CYCLE ARREST; CELL SURVIVAL; DRUG MECHANISM; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; NOTE; ONCOGENE C KIT; TREATMENT RESPONSE;

EID: 78649232794     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.6.8.13430     Document Type: Note

References (0)